Get the Stockscreener App
7.63
2.97%
0.22
After Hours:
7.31
-0.32
-4.19%
Champions Oncology Inc stock is traded at $7.63, with a volume of 14,326.
It is up +2.97% in the last 24 hours and down -2.74% over the past month.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
See More
Previous Close:
$7.41
Open:
$7.66
24h Volume:
14,326
Relative Volume:
0.44
Market Cap:
$105.12M
Revenue:
$49.98M
Net Income/Loss:
$-9.64M
P/E Ratio:
-10.75
EPS:
-0.71
Net Cash Flow:
$-4.86M
1W Performance:
+17.02%
1M Performance:
-2.74%
6M Performance:
-24.98%
1Y Performance:
+73.06%
1-Day Range:
$7.24
$7.66
1-Week Range:
$6.6904
$8.1999
52-Week Range:
$3.6001
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
Name
Champions Oncology Inc
Sector
Industry
Phone
410-369-0365
Address
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
7.63 | 96.03M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-18-19 | Initiated | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Stock (CSBR) Latest News
Understanding Champions Oncology Inc.’s price movementTrade Risk Summary & Daily Stock Trend Watchlist - Newser
Reversal indicators forming on Champions Oncology Inc. stockJuly 2025 Institutional & High Win Rate Trade Tips - Newser
Can technical indicators confirm Champions Oncology Inc.’s reversalJuly 2025 Setups & Safe Capital Growth Stock Tips - Newser
Using portfolio simulators with Champions Oncology Inc. includedWeekly Profit Summary & Long-Term Capital Growth Strategies - Newser
Published on: 2025-08-19 23:02:03 - Newser
Key resistance and support levels for Champions Oncology Inc.Fed Meeting & Daily Growth Stock Tips - Newser
How to use Fibonacci retracement on Champions Oncology Inc.Weekly Trade Summary & Detailed Earnings Play Strategies - Newser
Short interest data insights for Champions Oncology Inc.Weekly Gains Report & Entry Point Strategy Guides - Newser
Is Champions Oncology Inc. stock entering bullish territoryBreakout Watch & Low Risk High Win Rate Picks - Newser
How institutional ownership impacts Champions Oncology Inc. stockTrade Analysis Report & Momentum Based Trading Ideas - Newser
Using Ichimoku Cloud for Champions Oncology Inc. technicalsQuarterly Growth Report & Fast Gain Swing Alerts - Newser
Champions Oncology Inc. stock trendline breakdownTrade Risk Assessment & Capital Efficiency Focused Ideas - Newser
Key metrics from Champions Oncology Inc.’s quarterly data2025 AllTime Highs & Free Technical Confirmation Trade Alerts - Newser
Trend analysis for Champions Oncology Inc. this weekMarket Performance Summary & Verified Technical Signals - Newser
How to build a custom watchlist for Champions Oncology Inc.2025 Price Action Summary & Low Drawdown Trading Strategies - Newser
Is it too late to sell Champions Oncology Inc.Earnings Recap Report & Low Risk High Win Rate Stock Picks - Newser
How to recover losses in Champions Oncology Inc. stockJuly 2025 News Drivers & Weekly High Return Stock Forecasts - Newser
Heatmap analysis for Champions Oncology Inc. and competitorsRate Cut & Safe Entry Point Identification - Newser
Can Champions Oncology Inc. hit a new high this month2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Champions Oncology Inc. stock trend forecastEarnings Summary Report & Breakout Confirmation Alerts - Newser
How to build a dashboard for WisdomTree Inc. stock2025 Market Trends & Community Consensus Stock Picks - Newser
Can swing trading help recover from Champions Oncology Inc. lossesEntry Point & Expert Curated Trade Setup Alerts - Newser
Exit strategy if you’re trapped in Champions Oncology Inc.Quarterly Trade Summary & Weekly High Return Stock Opportunities - Newser
What the charts say about Champions Oncology Inc. todayJuly 2025 Breakouts & Safe Entry Point Identification - Newser
New Product Launches: Will They Boost OACCU Stock in 2025July 2025 Movers & Real-Time Volume Analysis - Newser
Will Uranium Royalty Corp. price bounce be sustainableMarket Trend Summary & Real-Time Market Sentiment Reports - Newser
Why Champions Oncology Inc. stock attracts strong analyst attentionWeekly Trading Summary & Safe Entry Momentum Stock Tips - Newser
How high can The Oncology Institute Inc. stock goWall Street Watch & Daily Oversold Bounce Ideas - Newser
GoPro Inc. Outperforms Peers on Volume MetricsJuly 2025 Closing Moves & Proven Capital Preservation Methods - newsyoung.net
Seeing Beyond Efficacy: How Radiolabeling Advances ADC Drug Development - MarketScreener
Is LINC building a consolidation baseWeekly Trend Report & AI Enhanced Execution Alerts - Newser
Historical volatility pattern of FCEL visualizedDividend Hike & Risk Controlled Daily Trade Plans - Newser
Chartists See Breakout Potential in MTCH2025 Key Lessons & Short-Term High Return Strategies - beatles.ru
Champions Oncology Inc Stock (CSBR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):